Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

February 8, 2017

First Doses of AXAL Administered to Phase 3 Cervical Cancer Trial Participants

News

The first doses of Advaxis‘ axalimogene filolisbac, or AXAL, have been administered to women with advanced cervical cancer in a Phase 3 trial of the treatment’s effectiveness after chemotherapy and radiation. The multicenter, ... Read more

February 3, 2017

Cancer Risk Higher for Those Who Don’t Follow-Up on Cervical Abnormalities

News

Women with moderate-to-severe changes in their cervical cells who don’t get follow-up testing or treatment are four times more likely to develop cervical cancer than women who receive treatment, according ... Read more

January 30, 2017

Largest Genomic Study of Cervical Cancer Identifies Novel Targets for Therapy

News

An extensive analysis of the genomic and molecular characteristics of cervical cancers has revealed that most of these cancers could be treated by targeting at least one of two major signaling ... Read more

January 27, 2017

Nearly Half of American Men Have HPV, but Vaccination Rates Are Low, Study Says

News

Vaccinating men for HPV could play a bigger role than previously thought in preventing the disease’s transmission — and the development of cancer associated with it — in both men ... Read more

January 11, 2017

Puma Adds More HER2-mutant Cervical-cancer Patients to PB272 Trial

News

Puma Biotechnology has added more cervical-cancer patients to its Phase 2 trial of PB272 (neratinib), a therapy that can be used alone or with other therapies to treat patients with ... Read more

November 23, 2016

CEL-SCI Asks FDA to Lift Partial Clinical Hold on Multikine for Head and Neck Cancers

News

CEL-SCI’s Phase 3 clinical trial assessing its investigational drug Multikine in patients with squamous cell carcinoma of the head and neck (SCCHN) recently was placed on partial clinical hold by ... Read more

November 21, 2016

Urine Test May Soon Be Able to Predict Likelihood of Cervical Cancer

News

Researchers at Johns Hopkins Medicine have developed a new, highly accurate urine test that can predict whether a woman is likely to develop cervical cancer. The test examines epigenetic changes ... Read more

November 2, 2016November 2, 2016

Majority of Cervical Cancer Patients in US Not Given Standard of Care, Study Finds

News

Standard of care for locally advanced cervical cancer includes external radiation, chemotherapy, and a form of internal radiation called brachytherapy. But results from a large study show that more than ... Read more

October 31, 2016October 31, 2016

HPV Vaccine Should Be Given Boys to Prevent Head and Neck Cancers, UK Study Says

News

Human papilloma virus (HPV)-associated head and neck cancers are on the increase, particularly in young white men. Recently, researchers have revealed that oral HPV infection is influenced by lifestyle choices, such as smoking and ... Read more

October 26, 2016

Advaxis’ Experimental Vaccine Increases Cervical Cancer 1-Year Survival Rates by 50% in Clinical Trial

News

Patients with persistent or recurrent metastatic carcinoma of the cervix (PRmCC) may strongly benefit from treatment with Advaxis‘ experimental vaccine axalimogene filolisbac (AXAL), according to preliminary data from the second ... Read more